Still think XXII is an excellent purchase under 1.35 with what the company has developed. However, how can anyone have any confidence in this market at this point? The election seems to be causing crazy volatility regardless of candidate preference.
$XXII..$1.37..start to regain some traction here after weeks of flailing in the $1.10-$1.25 range. Market starting to look better. Need that to be the case for biotech catalysts in the near-term.